| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CYTOGFR.2008.04.005 |
| P8608 | Fatcat ID | release_kbaonx6gu5edroi3eyzfms4enm |
| P932 | PMC publication ID | 2675004 |
| P698 | PubMed publication ID | 18515173 |
| P5875 | ResearchGate publication ID | 5336180 |
| P50 | author | Soumen Basak | Q60316456 |
| P2093 | author name string | Alexander Hoffmann | |
| P2860 | cites work | NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100 | Q24290908 |
| I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 | ||
| I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity | Q24318573 | ||
| Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers | Q24562579 | ||
| Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system | Q24641914 | ||
| A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription | Q24644412 | ||
| A fourth IkappaB protein within the NF-kappaB signaling module | Q24676472 | ||
| Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL | Q24681342 | ||
| Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues | Q24685416 | ||
| The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation | Q27766393 | ||
| Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity | Q27860643 | ||
| Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway | Q28214369 | ||
| Osteoimmunology: interplay between the immune system and bone metabolism | Q28303107 | ||
| Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
| Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes | Q28590628 | ||
| Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor | Q28615489 | ||
| Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B | Q28615823 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer | Q29614599 | ||
| The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 | ||
| Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
| RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF | Q34167602 | ||
| Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways | Q34173731 | ||
| Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. | Q34208671 | ||
| Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism | Q34227912 | ||
| Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. | Q34509419 | ||
| Circuitry of nuclear factor kappaB signaling | Q34514908 | ||
| Organogenesis of lymphoid tissues | Q35096187 | ||
| Lymphotoxin and LIGHT signaling pathways and target genes | Q35951798 | ||
| IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. | Q36117584 | ||
| Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. | Q36155317 | ||
| Distribution of NF-kappaB-binding sites across human chromosome 22 | Q36349337 | ||
| Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs | Q36369876 | ||
| Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function | Q36370717 | ||
| Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB. | Q36377290 | ||
| IkappaB kinase complexes: gateways to NF-kappaB activation and transcription | Q36637874 | ||
| Beyond IkappaBs: alternative regulation of NF-kappaB activity | Q36790420 | ||
| Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma | Q37314736 | ||
| Achieving stability of lipopolysaccharide-induced NF-kappaB activation | Q38320977 | ||
| Genetic analysis of NF- B/Rel transcription factors defines functional specificities | Q39962410 | ||
| Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells | Q40130375 | ||
| Stimulus specificity of gene expression programs determined by temporal control of IKK activity | Q40372675 | ||
| Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase | Q40504374 | ||
| Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation | Q40556549 | ||
| The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways | Q40696432 | ||
| Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. | Q40972388 | ||
| Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells | Q41273150 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways | Q42494588 | ||
| Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor | Q42943618 | ||
| Two pathways to NF-kappaB. | Q46113107 | ||
| Lymph node genesis is induced by signaling through the lymphotoxin beta receptor | Q47713223 | ||
| The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues | Q47713235 | ||
| Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. | Q52542561 | ||
| Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin | Q57258468 | ||
| NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1 | Q57675122 | ||
| Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression | Q62817899 | ||
| Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment | Q74244267 | ||
| Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines | Q74321402 | ||
| Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines | Q74405393 | ||
| Dendritic cell development and survival require distinct NF-kappaB subunits | Q77704364 | ||
| Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion | Q81447137 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 187-197 | |
| P577 | publication date | 2008-06-02 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | Crosstalk via the NF-kappaB signaling system | |
| P478 | volume | 19 |
| Q37207403 | A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family |
| Q89866097 | A universal reporter cell line for bioactivity evaluation of engineered cytokine products |
| Q37589257 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer |
| Q42396372 | Absolute Ligand Discrimination by Dimeric Signaling Receptors |
| Q40799292 | Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. |
| Q38873108 | Adipose tissue hypoxia and low-grade inflammation: a possible mechanism for ethanol-related glucose intolerance? |
| Q24303783 | Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner |
| Q60947955 | Anti-Inflammatory Activity of Leaf Extract via Modulating NF-κB and p38/JNK Pathways |
| Q92648402 | CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions |
| Q36677718 | Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway |
| Q34048288 | Caspase-1 recognizes extended cleavage sites in its natural substrates |
| Q34352064 | Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression |
| Q34325386 | Cobalt chloride attenuates oxidative stress and inflammation through NF-κB inhibition in human renal proximal tubular epithelial cells |
| Q33636430 | Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases |
| Q38095931 | Current concepts on the role of nitric oxide in portal hypertension |
| Q33393459 | Differential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblasts |
| Q35625381 | Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease |
| Q38719199 | Ethanol Extract of Potentilla supina Linne Suppresses LPS-induced Inflammatory Responses through NF-κB and AP-1 Inactivation in Macrophages and in Endotoxic mice. |
| Q90358677 | Expression of Inflammatory-Related NFκB Genes in Iranian Patients with Pterygium: A Case-Control Study |
| Q57480662 | Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury |
| Q55211516 | Gefitinib Inhibits Bleomycin-Induced Pulmonary Fibrosis via Alleviating the Oxidative Damage in Mice. |
| Q26745544 | How Mouse Macrophages Sense What Is Going On. |
| Q37812981 | IL-10 family of cytokines |
| Q37791756 | IL-20: Biological functions mediated through two types of receptor complexes |
| Q36251949 | Identification and application of anti-inflammatory compounds screening system based on RAW264.7 cells stably expressing NF-κB-dependent SEAP reporter gene |
| Q21133685 | Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling |
| Q28645567 | Increased Thymic Cell Turnover under Boron Stress May Bypass TLR3/4 Pathway in African Ostrich |
| Q89881557 | Integrative analysis suggests cell type-specific decoding of NF-κB dynamics |
| Q40757192 | Japanese encephalitis virus utilizes the canonical pathway to activate NF-kappaB but it utilizes the type I interferon pathway to induce major histocompatibility complex class I expression in mouse embryonic fibroblasts. |
| Q37239051 | Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity |
| Q34544660 | Lack of effect of the Salmonella deubiquitinase SseL on the NF-κB pathway |
| Q27690748 | Lessons from mathematically modeling the NF-κB pathway |
| Q54490483 | Low-dose, low-dose-rate proton radiation modulates CD4(+) T cell gene expression. |
| Q54958407 | Lymphotoxin α fine-tunes T cell clonal deletion by regulating thymic entry of antigen-presenting cells. |
| Q23922368 | Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust |
| Q53176759 | Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer. |
| Q41016309 | Medium-chain triglyceride ameliorates insulin resistance and inflammation in high fat diet-induced obese mice |
| Q28709497 | Modulation of NF-κB signalling by microbial pathogens |
| Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
| Q36011663 | NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis |
| Q37691276 | NF-κB signaling |
| Q36348582 | NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1 |
| Q41875074 | Negative interactions and feedback regulations are required for transient cellular response |
| Q39628101 | Neisseria lactamica attenuates TLR-1/2-induced cytokine responses in nasopharyngeal epithelial cells using PPAR-γ |
| Q43245098 | Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension |
| Q37694101 | Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. |
| Q35347865 | Nuclear initiated NF-κB signaling: NEMO and ATM take center stage |
| Q47729007 | Oral subchronic exposure to silver nanoparticles causes renal damage through apoptotic impairment and necrotic cell death. |
| Q37175126 | Pancreatic acinar cell nuclear factor κB activation because of bile acid exposure is dependent on calcineurin |
| Q39474567 | Potent anti-inflammatory effect of a novel furan-2,5-dione derivative, BPD, mediated by dual suppression of COX-2 activity and LPS-induced inflammatory gene expression via NF-κB inactivation |
| Q42053204 | Principles of modular tumor therapy |
| Q47101584 | Protective role of tenuigenin on sepsis-induced acute kidney injury in mice |
| Q26753142 | ROS and ROS-Mediated Cellular Signaling |
| Q52689527 | Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease. |
| Q37579634 | Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs |
| Q41682794 | Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway |
| Q34707943 | Role of adiponectin and proinflammatory gene expression in adipose tissue chronic inflammation in women with metabolic syndrome |
| Q38779804 | Signaling via the NFκB system. |
| Q37586125 | Signalling crosstalk in B cells: managing worth and need |
| Q39385521 | Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF-κB p65. |
| Q91711303 | Substrate complex competition is a regulatory motif that allows NFκB RelA to license but not amplify NFκB RelB |
| Q89682811 | Systematic Analysis of Monoterpenes: Advances and Challenges in the Treatment of Peptic Ulcer Diseases |
| Q42759660 | TGF-β1 induces podocyte injury through Smad3-ERK-NF-κB pathway and Fyn-dependent TRPC6 phosphorylation |
| Q37412511 | TNF-alpha and its inhibitors in cancer |
| Q36653657 | Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis |
| Q37502685 | Targeting innate immunity protein kinase signalling in inflammation |
| Q26786135 | The dual role of iNOS in cancer |
| Q28538944 | The gastroprotective effect of menthol: involvement of anti-apoptotic, antioxidant and anti-inflammatory activities |
| Q38318217 | The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy |
| Q33685419 | The regulatory logic of the NF-kappaB signaling system |
| Q27004003 | Thymic epithelial cell development and differentiation: cellular and molecular regulation |
| Q37593760 | Thymic epithelial cell development and its dysfunction in human diseases. |
| Q42779520 | Troglitazone-activated PPARγ inhibits LPS-induced lung alveolar type II epithelial cells injuries via TNF-α. |
| Q53632800 | Vitamin D attenuates inflammation in CFTR knockdown intestinal epithelial cells but has no effect in cells with intact CFTR. |
Search more.